ULTRAGENYX PHARMACEUTICAL INC. - COMMON STOCK
43.40
19-4月-24 09:55:56
15 分の遅延
株式
+0.02
+0.05%
本日の幅
43.00 - 43.92
ISIN
N/A
ソース
NASDAQ
-
15 4 2024 06:00:00 提供 Nasdaq GlobeNewswire
-
12 4 2024 15:22:53 提供 Nasdaq GlobeNewswire
-
12 4 2024 07:00:00 提供 Nasdaq GlobeNewswire
-
Ultragenyx Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
22 3 2024 15:00:00 提供 Nasdaq GlobeNewswire
-
Ultragenyx to Participate at Investor Conferences in March
27 2 2024 15:30:00 提供 Nasdaq GlobeNewswire
-
Ultragenyx Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
23 2 2024 15:05:00 提供 Nasdaq GlobeNewswire
-
Ultragenyx Reports Fourth Quarter and Full Year 2023 Financial Results and Corporate Update
15 2 2024 15:01:00 提供 Nasdaq GlobeNewswire
-
08 2 2024 15:00:00 提供 Nasdaq GlobeNewswire
-
05 2 2024 15:05:00 提供 Nasdaq GlobeNewswire
-
25 1 2024 15:05:00 提供 Nasdaq GlobeNewswire
-
Ultragenyx Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
19 1 2024 15:00:00 提供 Nasdaq GlobeNewswire
-
07 1 2024 10:00:00 提供 Nasdaq GlobeNewswire
-
03 1 2024 07:00:00 提供 Nasdaq GlobeNewswire
-
Ultragenyx to Present at the 42nd Annual J.P. Morgan Healthcare Conference
02 1 2024 15:05:00 提供 Nasdaq GlobeNewswire
-
Ultragenyx Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
21 12 2023 15:30:00 提供 Nasdaq GlobeNewswire
-
Ultragenyx to Participate at Investor Conferences in November
20 11 2023 15:30:00 提供 Nasdaq GlobeNewswire
-
Ultragenyx Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
17 11 2023 15:30:00 提供 Nasdaq GlobeNewswire
- <<
- <
- 1
- >